knowledge -WSS

knowledge

author：leisure time 2025-09-01 15:22:13 - browse：5639

Adam's take main illustration — Molly Ferguson/STAT

Behind the stellar commercial launch of Amylyx Pharmaceuticals’ treatment for ALS lies an uncomfortable question: Does early success of the drug, called Relyvrio, make it more complicated, perhaps impossible, to pull it from the market if we find out next year that it doesn’t work?

On Monday night, Amylyx said Relyvrio sales totaled $22 million in 2022 — a period that covers slightly more than one calendar quarter given the drug’s U.S. approval last September. The company said approximately 1,300 ALS patients were on Relyvrio at the end of December, and it expects that number to at least double by the end of the first quarter.

“We’re probably going to double, closer to triple, our revenue in Q1,” said James Frates, Amylyx’s chief financial officer, speaking on Monday night’s conference call.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： A double vaccine crisis is endangering millions of children

hotspot

WSS

FDA official pushes for dedicated emerging pathogens team

FDA official pushes for dedicated emerging pathogens team

Baltimore teen accused of firing into crowd during block party mass shooting

Majority of Americans think Trump's Ga. election interference case is serious: POLL

Patient advocates sound warning on FDA proposal on salt intake

Will.i.am, Britney Spears release new single, 'Mind Your Business'

focus

knowledge

Wikipedia

Bright Health sells Medicare Advantage business to Molina

Artificial intelligence advances fuel industry trying to preserve loved ones after death

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Hilary expected to bring catastrophic, life

The cancer drug shortage isn’t new — and neither are the solutions

Baltimore teen accused of firing into crowd during block party mass shooting

BioMarin wins approval for gene therapy to treat hemophilia A

Body of missing toddler recovered in Delaware River days after flood: Police

Supreme Court strikes down use of affirmative action

White House launches permanent pandemic office

hotspot

Southern California school board OKs curriculum after Gov. Gavin Newsom threatened a $1.5M fine

Baltimore teen accused of firing into crowd during block party mass shooting

As Taiwan prepares for anti

Artificial intelligence advances fuel industry trying to preserve loved ones after death

Russian special forces kill a gunman who broke into a private house near Moscow

Court strikes down limits on filming of police in Arizona

entertainment

hotspot

explore

focus